Literature DB >> 16247657

Treatment strategy for cutaneous malignant melanoma.

Arata Tsutsumida1, Hiroshi Furukawa, Yuhei Yamamoto, Tsuneki Sugihara.   

Abstract

The incidence of cutaneous malignant melanoma has been rising in Japan. With education, recent advances in accurate diagnosis and establishment of the concept, more lesions are being diagnosed as early melanomas, for which there is a high cure rate. However, many patients will still present with thicker lesions or nodal involvement, which carries a significantly worse prognosis. Recently there have been advances in the management and treatment of cutaneous melanoma. This article reviews the clinical evidence behind the current treatment recommendations for primary and recurrent cutaneous melanoma in Japan.

Entities:  

Mesh:

Year:  2005        PMID: 16247657     DOI: 10.1007/s10147-005-0522-9

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  53 in total

1.  Clinical evaluation of cutaneous malignant melanoma with histologically involved lymph node metastases.

Authors:  T Sugihara; T Yoshida; T Ohura; A Ohkawara; M Kumakiri
Journal:  J Dermatol       Date:  1991-10       Impact factor: 4.005

2.  Efficacy of lymphatic mapping, sentinel lymphadenectomy, and selective complete lymph node dissection as a therapeutic procedure for early-stage melanoma.

Authors:  R Essner; A Conforti; M C Kelley; L Wanek; S Stern; E Glass; D L Morton
Journal:  Ann Surg Oncol       Date:  1999 Jul-Aug       Impact factor: 5.344

3.  Frequency of nonsentinel lymph node metastasis in melanoma.

Authors:  Kelly M McMasters; Sandra L Wong; Michael J Edwards; Celia Chao; Merrick I Ross; R Dirk Noyes; Vicki Viar; Patricia B Cerrito; Douglas S Reintgen
Journal:  Ann Surg Oncol       Date:  2002-03       Impact factor: 5.344

4.  Local recurrence in malignant melanoma: long-term results of the multiinstitutional randomized surgical trial.

Authors:  C P Karakousis; C M Balch; M M Urist; M M Ross; T J Smith; A A Bartolucci
Journal:  Ann Surg Oncol       Date:  1996-09       Impact factor: 5.344

5.  Management of symptomatic malignant melanoma of the gastrointestinal tract.

Authors:  A C Berger; J F Buell; D Venzon; A R Baker; S K Libutti
Journal:  Ann Surg Oncol       Date:  1999-03       Impact factor: 5.344

6.  A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma.

Authors:  H Starz; B R Balda; K U Krämer; H Büchels; H Wang
Journal:  Cancer       Date:  2001-06-01       Impact factor: 6.860

Review 7.  Current state of treatment for primary cutaneous melanoma.

Authors:  E S Chung; M S Sabel; V K Sondak
Journal:  Clin Exp Med       Date:  2004-10       Impact factor: 3.984

8.  Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.

Authors:  J E Gershenwald; M I Colome; J E Lee; P F Mansfield; C Tseng; J J Lee; C M Balch; M I Ross
Journal:  J Clin Oncol       Date:  1998-06       Impact factor: 44.544

Review 9.  Surgical treatment of malignant melanoma.

Authors:  Richard Essner
Journal:  Surg Clin North Am       Date:  2003-02       Impact factor: 2.741

10.  Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells.

Authors:  Yasuto Akiyama; Ryuji Tanosaki; Naoki Inoue; Makiko Shimada; Yukie Hotate; Akifumi Yamamoto; Naoya Yamazaki; Ichiro Kawashima; Ikuei Nukaya; Kazutoh Takesako; Kouji Maruyama; Yoichi Takaue; Ken Yamaguchi
Journal:  J Transl Med       Date:  2005-01-28       Impact factor: 5.531

View more
  3 in total

1.  Clinicopathological correlation for the role of fluorodeoxyglucose positron emission tomography computed tomography in detection of choroidal malignant melanoma.

Authors:  Toshihiko Matsuo; Yuka Ogino; Kouichi Ichimura; Takehiro Tanaka; Mitsumasa Kaji
Journal:  Int J Clin Oncol       Date:  2013-03-01       Impact factor: 3.402

2.  Sentinel node biopsy versus elective lymph node dissection in patients with cutaneous melanoma in a Japanese population.

Authors:  Arata Tsutsumida; Hiroshi Furukawa; Yuhei Yamamoto; Katsumi Horiuchi; Tetsunori Yoshida; Hidehiko Minakawa; Satoru Fujii; Naoki Murao; Hiroaki Kuwahara; Toshiyuki Minamimoto; Hirotaka Fujioka; Taisuke Sakamoto; Toyohiro Honma
Journal:  Int J Clin Oncol       Date:  2007-08-20       Impact factor: 3.402

3.  Expression of a suicidal gene under control of the human secreted protein acidic and rich in cysteine (SPARC) promoter in tumor or stromal cells led to the inhibition of tumor cell growth.

Authors:  María V Lopez; Patricia Blanco; Diego L Viale; Eduardo G Cafferata; Cecilia Carbone; David Gould; Yuti Chernajovsky; Osvaldo L Podhajcer
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.